Device
Extracorporeal Shock Waves
Extracorporeal Shock Waves is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
completed125%
recruiting125%
unknown250%
Recent Activity
1 active trials
Showing 4 of 4
recruitingnot_applicable
Comparing ESWT Doses for Post-Stroke Ankle Spasticity Treatment
NCT05878223
completednot_applicable
Effect of Extracorporeal Shockwave Therapy Before Postural Correction Exercise in Adults With Forward Head Posture
NCT05855772
unknownnot_applicable
Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves
NCT05584163
unknownphase_2
Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis
NCT02904785
Clinical Trials (4)
Showing 4 of 4 trials
NCT05878223Not Applicable
Comparing ESWT Doses for Post-Stroke Ankle Spasticity Treatment
NCT05855772Not Applicable
Effect of Extracorporeal Shockwave Therapy Before Postural Correction Exercise in Adults With Forward Head Posture
NCT05584163Not Applicable
Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves
NCT02904785Phase 2
Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4